ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA
Clinical trials for ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes on brain tumors: first human trial begins
Disease control Recruiting nowThis early-phase study tests an oral drug called ONC206 in 102 adults with brain tumors that have come back or are rare. The main goal is to find the safest dose and understand side effects. Participants take the drug by mouth on a weekly schedule, and researchers monitor for any…
Matched conditions: ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 03:16 UTC
-
Kids on brain tumor drugs get Long-Term checkup
Disease control Recruiting nowThis study follows children who have already taken dabrafenib and/or trametinib for certain brain tumors. Researchers will monitor side effects and track growth over time. The goal is to understand the long-term safety of these medications in young patients.
Matched conditions: ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 03:10 UTC